Aspirin Use Linked to Fewer Breast Cancer Deaths

Study finds use of aspirin is also associated with a lower risk of distant recurrence
By A. Agrawal, PhD
HealthDay Reporter

WEDNESDAY, Feb. 17 (HealthDay News) -- Women with breast cancer who take aspirin several days a week have a lower risk of death or recurrence, according to a study published online Feb. 15 in the Journal of Clinical Oncology.

Michelle D. Holmes, M.D., of Brigham and Women's Hospital in Boston, and colleagues examined the association between self-reported aspirin use and mortality among 4,164 female registered nurses with breast cancer.

The researchers recorded 341 deaths from breast cancer. More frequent, current aspirin use was associated with a significantly lower risk of death, with an adjusted relative risk of 1.07 for use once a week and an adjusted relative risk of 0.36 for use six to seven days per week. The association was not significantly affected by stage, menopausal status, body mass index, or estrogen receptor status. Similar results were observed for distant recurrence, with an adjusted relative risk of 0.91 for aspirin use once a week and an adjusted relative risk of 0.40 for use six to seven days per week.

"Among women living at least one year after a breast cancer diagnosis, aspirin use was associated with a decreased risk of distant recurrence and breast cancer death," the authors conclude.

Abstract
Full Text

Copyright © 2010 HealthDay. All rights reserved.

Powered by

Featured Jobs



Benefits of Membership

FREE E-Newsletters
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues

CESaver
Join our CESaver program to earn up to 100 contact hours for only $34.95
Register Now

Lippincott's NursingCenter.com
Explore a world of online resources

Become a Member